IPO News and Updates

4/19/14


First Foundation, which provides wealth management to high net-worth individuals and commercial banking services to businesses and consumers, filed on Saturday with the SEC to raise up to $58 million in an initial public offering. The Irvine, CA-based company, which was founded in 2006 and booked $58 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol FFWM. First Foundation initially filed confidentially on March 19, 2014. Sandler O'Neill and Keefe Bruyette Woods are the joint bookrunners on the deal. No pricing terms were disclosed.


Keywords: FFWM

4/18/14


Zafgen, a clinical-stage biotech developing a treatment for obesity, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Cambridge, MA-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol ZFGN. Zafgen initially filed confidentially on January 31, 2014. Leerink Partners and Cowen & Company are the joint bookrunners on the deal. No pricing terms were disclosed.


Keywords: ZFGN, biotech

4/18/14


Chukong Technologies, a Chinese mobile game developer and publisher that also maintains an open-source engine, filed on Friday with the SEC to raise up to $150 million in an initial public offering. The Beijing, China-based company, which was founded in 2010 and booked $92 million in sales for the fiscal year ended December 31, 2013, plans to list on the NASDAQ. It initially filed confidentially on January 17, 2014. Morgan Stanley, Deutsche Bank and China Renaissance Securities are the joint bookrunners on the deal. No pricing terms were disclosed and no ticker has been announced.


Keywords: Chukong

4/18/14


Sundance Energy Australia, a US oil and gas E&P operating in the Eagle Ford and Woodford formations, withdrew its plans for an initial public offering on Friday citing poor market conditions. The Denver, CO-based company is also listed on the Australian Securities Exchange (ticker SEA). The Denver, CO-based company was founded in 2004 and booked $63 million in sales for the 12 months ended September 30, 2013. SNDE. Wells Fargo Securities, Canaccord Genuity and UBS Investment Bank were set to be the joint bookrunners on the deal.


Keywords: SNDE

Archived News Headlines
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: IPO investment firm Renaissance Capital (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Global IPO Fund (symbol: IPOSX) or the Renaissance IPO ETF (symbol: IPO), may have investments in securities of companies mentioned.
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE. The S&P 500 index components are determined by S&P Dow Jones Indices.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO" (the “ETF”) and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETF and the Mutual Fund (the “Funds”) invest in companies that have recently completed their initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. The Funds may also be subject to information technology risk and small and mid-capitalization company risk due to a greater number of IPOs in these sectors. The Funds may hold securities in the form of Depository Receipts, REITs, Master Limited Partnerships (MLPs) which have greater risks than common shares. The strategy has high portfolio turnover and securities lending risks. ETF returns may not match the return of the respective index. The ETF is classified as a non-diversified investment company and is subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with information about the Funds, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETF, 1-866-486-6645.